Susquehanna International Group
RCEL icon

Susquehanna International Group’s Avita Medical RCEL Stock Holding History

Susquehanna International Group’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,600
Closed -$257K – 13139
2023
Q3 		$257K Buy
17,600
+5,000
+40% +$84.6K ﹤0.01% 9687
2023
Q2 		$214K Buy
+12,600
New +$185K ﹤0.01% 10142
2022
Q2 		– Sell
-29,000
Closed -$246K – 13751
2022
Q1 		$246K Buy
+29,000
New +$267K ﹤0.01% 10749
2021
Q4 		– Sell
-88,700
Closed -$1.57M – 13758
2021
Q3 		$1.57M Buy
+88,700
New +$1.67M ﹤0.01% 6359
2021
Q2 		– Sell
-34,600
Closed -$686K – 13138
2021
Q1 		$686K Buy
34,600
+12,500
+57% +$291K ﹤0.01% 8720
2020
Q4 		$411K Buy
22,100
+5,400
+32% +$118K ﹤0.01% 8681
2020
Q3 		$420K Sell
16,700
-3,600
-18% -$89.7K ﹤0.01% 8032
2020
Q2 		$620K Buy
+20,300
New +$621K ﹤0.01% 6909

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group's RCEL Position: Q4 2025 in Review

Susquehanna International Group sold out of Avita Medical (RCEL) in Q4 2025, closing a stake of 35,193 shares — an estimated $180K sold.

Susquehanna International Group first reported a position in RCEL in Q2 2020 and held it in 20 quarters. The position peaked at $3.21M in Q1 2023. 67 funds tracked by Wall St. Rank hold RCEL as of Q4 2025.

  • Susquehanna International Group reported no remaining Avita Medical position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 35,193 Avita Medical shares in Q4 2025, an estimated $180K.
  • Susquehanna International Group first reported a position in Avita Medical in Q2 2020 and held it in 20 quarters.
  • Susquehanna International Group's Avita Medical position peaked at $3.21M in Q1 2023.
  • 67 funds tracked by Wall St. Rank held Avita Medical as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.